Shopping Cart
- Remove All
- Your shopping cart is currently empty
GSK4028 is the enantiomeric negative control of GSK4027, a PCAF/GCN5 bromodomain chemical probe, with a pIC50 of 4.9 in a TR-FRET assay.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $1,470 | 8-10 weeks | |
10 mg | $2,200 | 8-10 weeks | |
25 mg | $3,740 | 8-10 weeks |
Description | GSK4028 is the enantiomeric negative control of GSK4027, a PCAF/GCN5 bromodomain chemical probe, with a pIC50 of 4.9 in a TR-FRET assay. |
Targets&IC50 | PCAF/GCN5:4.9(pIC50) |
In vitro | GSK4028 also demonstrates potency toward BRD4 BD1 and BRD9 inTR-FRET assay with pIC50s of <4.3 and 4.5±0.13, respectively.GSK4028 is the enantiomeric negative control of GSK4027, which is a PCAF/GCN5 bromodomain chemical probe, the pIC50 of GSK4028 is 4.9. |
Molecular Weight | 377.28 |
Formula | C17H21BrN4O |
Cas No. | 2079886-19-2 |
Relative Density. | 1.45 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.